TipRanks
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
US Market
ORIC
Oric Pharmaceuticals
RESEARCH TOOLSreports
Want to see ORIC full AI Analyst Report?

Oric Pharmaceuticals (ORIC) Stock News & Sentiment

529 Followers
Boris Peaker Reiterates Buy on ORIC, Sees Compelling Risk-Reward with Unchanged $25 Price Target
Premium
Ratings
Boris Peaker Reiterates Buy on ORIC, Sees Compelling Risk-Reward with Unchanged $25 Price Target
4d ago
ORIC
Analyst Reiterates Buy on ORIC Pharmaceuticals, Citing Best-in-Class Potential for Enozertinib and Maintaining $27 Price Target
Premium
Ratings
Analyst Reiterates Buy on ORIC Pharmaceuticals, Citing Best-in-Class Potential for Enozertinib and Maintaining $27 Price Target
4d ago
ORIC
Oric Highlights Strong Enozertinib Data, Eyes Phase 3
Premium
Company Announcements
Oric Highlights Strong Enozertinib Data, Eyes Phase 3
8d ago
8K
ORIC
ORIC Pharmaceuticals: Buy Rating Reiterated on Strong Enosertinib Efficacy and Safety, Price Target Unchanged at $26
Premium
Ratings
ORIC Pharmaceuticals: Buy Rating Reiterated on Strong Enosertinib Efficacy and Safety, Price Target Unchanged at $26
12d ago
ORIC
Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial
Premium
Company Announcements
Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial
2M ago
ORIC
ORIC Pharmaceuticals: Buy Rating Reaffirmed with Unchanged $25 Price Target on Multiple Oncology Catalysts and mCRPC Upside
Premium
Ratings
ORIC Pharmaceuticals: Buy Rating Reaffirmed with Unchanged $25 Price Target on Multiple Oncology Catalysts and mCRPC Upside
3M ago
ORIC
Oric Pharmaceuticals Expands Inducement Equity Incentive Plan
Premium
Company Announcements
Oric Pharmaceuticals Expands Inducement Equity Incentive Plan
3M ago
8K
ORIC
More ORIC News >

ORIC News on the Web

Wells Fargo Remains a Buy on Oric Pharmaceuticals (ORIC)
TipRanks News
Bullish
ORIC Pharmaceuticals (ORIC) CFO Dominic Piscitelli Sells 13,400 Shares
GuruFocus News
Neutral
ORIC Pharmaceuticals CFO Dominic Piscitelli Sells 600 Shares of ORIC Stock
GuruFocus News
Neutral
ORIC (ORIC) Doubles Down On Prostate Cancer With Phase 3 Launch
Insider Monkey
Neutral
Oric Pharmaceuticals initiates Himalayas-1 trial
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Biomea Fusion (BMEA) and Senseonics Holdings (SENS)
TipRanks News
Bullish
Oric Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
GuruFocus News
Neutral

News Score - Last 7 Days

Very Positive
ORIC
Sector Average
Media Buzz
This Week12 articles
Weekly Average4 articles
News Sentiment
This Week89%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ORIC’s Media Buzz Sentiment?
12 articles about ORIC were published this week. In an average week, 4 articles are published.
    What is ORIC’s weekly average amount of articles?
    In an average week, 4 articles about ORIC are published.
      What is ORIC’s News Sentiment?
      89% of articles about ORIC were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CNCCentene
        GMABGenmab
        LHLabcorp Holdings
        KIDSOrthoPediatrics
        DXCMDexcom
        Showing the stocks with the most bullish news sentiment over the past week